Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]

Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]

© 2018 The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused.

Bibliographic Details
Main Authors: Manu, K., Shanmugam, M., Ramachandran, L., Li, F., Siveen, K., Chinnathambi, A., Zayed, M., Alharbi, S., Arfuso, Frank, Kumar, Alan Prem, Ahn, K., Sethi, G.
Format: Journal Article
Published: Elsevier 2018
Online Access:http://hdl.handle.net/20.500.11937/67036

Internet

http://hdl.handle.net/20.500.11937/67036

Similar Items